Published in
Taylor and Francis Group, Journal of Dermatological Treatment, 2(33), p. 1146-1149, 2020
DOI: 10.1080/09546634.2020.1773379
Links
Tools
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis
Journal article published in 2020 by
M. C. Fargnoli,
M. Esposito,
S. Ferrucci 
,
G. Girolomoni,
A. Offidani,
A. Patrizi,
K. Peris,
A. Costanzo,
G. Malara,
G. Pellacani,
M. Romanelli,
P. Amerio,
A. Cristaudo,
M. L. Flori,
A. Motolese
and other authors.
,
G. Girolomoni,
A. Offidani,
A. Patrizi,
K. Peris,
A. Costanzo,
G. Malara,
G. Pellacani,
M. Romanelli,
P. Amerio,
A. Cristaudo,
M. L. Flori,
A. Motolese
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 